CoChat

Greater incidence of depression with hypnotic use than with placebo

Open access
Kripke, Daniel F · 2007 · BMC Psychiatry
Cited by 96

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Although it has been claimed that insomnia causes an increased risk for depression, adequate controlled trials testing this hypothesis have not been available. This study contrasted the incidence of depression among subjects receiving hypnotics in randomized controlled trials versus those receiving placebo. METHODS: The incidence of depression among patients randomized to hypnotic drugs or placebo was compiled from prescribing information approved by the United States Food and Drug Administration (FDA) and from FDA New Drug Application documents. Available data for zolpidem, zaleplon, eszopiclone, and ramelteon were accessed. RESULTS: Data for 5535 patients randomized to a hypnotic and for 2318 randomized to placebo were compiled. The incidence of depression was 2.0% among participants randomized to hypnotics as compared to 0.9% among those randomized in parallel to placebo (p < 0.002). CONCLUSION: Modern hypnotics were associated with an increased incidence of depression in data released by the FDA. This suggests that when there is a risk of depression, hypnotics may be contra-indicated. Preventive treatments such as antidepressant drugs, cognitive-behavioral therapy, or bright light might be preferred. Limitations in the FDA data prevented a formal meta-analysis, and there was a lack of information about drop-out rates and definitions of depression. Trials specifically designed to detect incident depression when treating insomnia with hypnotic drugs and better summarization of adverse events in trials submitted to the FDA are both necessary.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-244x-7-42

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 9

  1. Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ: Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol. 1997, 146: 105-114. · DOI · Paper page
  2. Association AP: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 2000, Washington, D.C., American Psychiatric Association, Fourth Edition, Text Revision
  3. Fogel J, Eaton WW, Ford DE: Minor depression as a predictor of the first onset of major depressive disorder over a 15-year follow-up. Acta Psychiatr Scand. 2006, 113: 36-43. 10.1111/j.1600-0447.2005.00654.x. · DOI · Paper page
  4. Allgulander C, Nasman B: Regular hypnotic drug treatment in a sample of 32,679 Swedes: associations with somatic and mental health, inpatient psychiatric diagnoses and suicide, derived with automated record-linkage. Psychosom Med. 1991, 53(1): 101-108. · DOI · Paper page
  5. Kripke DF, Klauber MR, Wingard DL, Fell RL, Assmus JD, Garfinkel L: Mortality hazard associated with prescription hypnotics. Biol Psychiatry. 1998, 43: 687-693. 10.1016/S0006-3223(97)00292-8. · DOI · Paper page
  6. Kripke DF: Evidence That New Hypnotics Cause Cancer. 2006, eScholarship Repository, University of California, [ http://repositories.cdlib.org/ucsdpsych/3 ]
  7. Dixon S, Morgan K, Mathers N, Thompson J, Tomeny M: Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia. Behav Sleep Med. 2006, 4: 71-84. 10.1207/s15402010bsm0402_1. · DOI · Paper page
  8. Giles J: Drug trials: stacking the deck. Nature. 2006, 440: 270-272. 10.1038/440270a. · DOI
  9. Kripke DF: The Dark Side of Sleeping Pills. 2006, [ http://www.DarkSideOfSleepingPills.com ]

Cited by

See all 96

Metadata

Authors
Kripke, D. F.
Venue
BMC Psychiatry
Published
2007-08-21
Volume
7
Issue
1
Pages
42-42
ISSN
1471-244X (ISSN-L)
OpenAlex
W2093669603
Cited by
96
References
16
FWCI
7.09
Type
journal article
Language
en
Open access
gold
Licence
creativecommons.org/licenses/by/2.0 (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Greater incidence of depression with hypnotic use than with placebo. https://app.cochat.ai/papers/10.1186/1471-244x-7-42
The paper
Kripke, D. F. (2007). Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry. https://doi.org/10.1186/1471-244x-7-42

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.